Global Vitamin K Antagonists (VKA) Market Insights, Forecast to 2025

Publisher Name :
Date: 01-May-2019
No. of pages: 113
Inquire Before Buying

Vitamin K is a kind of substance with biological activity of leaf green quinone.

Rising demand from Asia-Pacific region a major driver for the growth of the market.

The global Vitamin K Antagonists (VKA) market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Vitamin K Antagonists (VKA) market based on company, product type, end user and key regions.

This report studies the global market size of Vitamin K Antagonists (VKA) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Vitamin K Antagonists (VKA) in these regions.

This research report categorizes the global Vitamin K Antagonists (VKA) market by top players/brands, region, type and end user. This report also studies the global Vitamin K Antagonists (VKA) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Sanofi

- Bristol-Myers Squibb

- Bayer

- Johnson & Johnson

- Genentech (Roche)

- Boehringer Ingelheim

- Lilly

- Daiichi Sankyo

- Otsuka

- AstraZeneca

- Pfizer

- Aspen

- The Medicines Company

Market size by Product

- Oral Vitamin K Antagonists

- Injection Vitamin K Antagonists

Market size by End User

- VTE

- ACS/MI

- AF

- Others

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Vitamin K Antagonists (VKA) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Vitamin K Antagonists (VKA) market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Vitamin K Antagonists (VKA) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Vitamin K Antagonists (VKA) submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Vitamin K Antagonists (VKA) are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Vitamin K Antagonists (VKA) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Vitamin K Antagonists (VKA) Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Vitamin K Antagonists (VKA) Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Vitamin K Antagonists (VKA) Market Size Growth Rate by Product
1.4.2 Oral Vitamin K Antagonists
1.4.3 Injection Vitamin K Antagonists
1.5 Market by End User
1.5.1 Global Vitamin K Antagonists (VKA) Market Size Growth Rate by End User
1.5.2 VTE
1.5.3 ACS/MI
1.5.4 AF
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Vitamin K Antagonists (VKA) Market Size
2.1.1 Global Vitamin K Antagonists (VKA) Revenue 2014-2025
2.1.2 Global Vitamin K Antagonists (VKA) Sales 2014-2025
2.2 Vitamin K Antagonists (VKA) Growth Rate by Regions
2.2.1 Global Vitamin K Antagonists (VKA) Sales by Regions
2.2.2 Global Vitamin K Antagonists (VKA) Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Vitamin K Antagonists (VKA) Sales by Manufacturers
3.1.1 Vitamin K Antagonists (VKA) Sales by Manufacturers
3.1.2 Vitamin K Antagonists (VKA) Sales Market Share by Manufacturers
3.1.3 Global Vitamin K Antagonists (VKA) Market Concentration Ratio (CR5 and HHI)
3.2 Vitamin K Antagonists (VKA) Revenue by Manufacturers
3.2.1 Vitamin K Antagonists (VKA) Revenue by Manufacturers (2014-2019)
3.2.2 Vitamin K Antagonists (VKA) Revenue Share by Manufacturers (2014-2019)
3.3 Vitamin K Antagonists (VKA) Price by Manufacturers
3.4 Vitamin K Antagonists (VKA) Manufacturing Base Distribution, Product Types
3.4.1 Vitamin K Antagonists (VKA) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Vitamin K Antagonists (VKA) Product Type
3.4.3 Date of International Manufacturers Enter into Vitamin K Antagonists (VKA) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Vitamin K Antagonists (VKA) Sales by Product
4.2 Global Vitamin K Antagonists (VKA) Revenue by Product
4.3 Vitamin K Antagonists (VKA) Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Vitamin K Antagonists (VKA) Breakdown Data by End User
6 North America
6.1 North America Vitamin K Antagonists (VKA) by Countries
6.1.1 North America Vitamin K Antagonists (VKA) Sales by Countries
6.1.2 North America Vitamin K Antagonists (VKA) Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Vitamin K Antagonists (VKA) by Product
6.3 North America Vitamin K Antagonists (VKA) by End User
7 Europe
7.1 Europe Vitamin K Antagonists (VKA) by Countries
7.1.1 Europe Vitamin K Antagonists (VKA) Sales by Countries
7.1.2 Europe Vitamin K Antagonists (VKA) Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Vitamin K Antagonists (VKA) by Product
7.3 Europe Vitamin K Antagonists (VKA) by End User
8 Asia Pacific
8.1 Asia Pacific Vitamin K Antagonists (VKA) by Countries
8.1.1 Asia Pacific Vitamin K Antagonists (VKA) Sales by Countries
8.1.2 Asia Pacific Vitamin K Antagonists (VKA) Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Vitamin K Antagonists (VKA) by Product
8.3 Asia Pacific Vitamin K Antagonists (VKA) by End User
9 Central & South America
9.1 Central & South America Vitamin K Antagonists (VKA) by Countries
9.1.1 Central & South America Vitamin K Antagonists (VKA) Sales by Countries
9.1.2 Central & South America Vitamin K Antagonists (VKA) Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Vitamin K Antagonists (VKA) by Product
9.3 Central & South America Vitamin K Antagonists (VKA) by End User
10 Middle East and Africa
10.1 Middle East and Africa Vitamin K Antagonists (VKA) by Countries
10.1.1 Middle East and Africa Vitamin K Antagonists (VKA) Sales by Countries
10.1.2 Middle East and Africa Vitamin K Antagonists (VKA) Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Vitamin K Antagonists (VKA) by Product
10.3 Middle East and Africa Vitamin K Antagonists (VKA) by End User
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Company Business Overview
11.1.3 Sanofi Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Sanofi Vitamin K Antagonists (VKA) Products Offered
11.1.5 Sanofi Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Company Business Overview
11.2.3 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Products Offered
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Company Business Overview
11.3.3 Bayer Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Bayer Vitamin K Antagonists (VKA) Products Offered
11.3.5 Bayer Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Company Business Overview
11.4.3 Johnson & Johnson Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Johnson & Johnson Vitamin K Antagonists (VKA) Products Offered
11.4.5 Johnson & Johnson Recent Development
11.5 Genentech (Roche)
11.5.1 Genentech (Roche) Company Details
11.5.2 Company Business Overview
11.5.3 Genentech (Roche) Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Genentech (Roche) Vitamin K Antagonists (VKA) Products Offered
11.5.5 Genentech (Roche) Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Details
11.6.2 Company Business Overview
11.6.3 Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Boehringer Ingelheim Vitamin K Antagonists (VKA) Products Offered
11.6.5 Boehringer Ingelheim Recent Development
11.7 Lilly
11.7.1 Lilly Company Details
11.7.2 Company Business Overview
11.7.3 Lilly Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Lilly Vitamin K Antagonists (VKA) Products Offered
11.7.5 Lilly Recent Development
11.8 Daiichi Sankyo
11.8.1 Daiichi Sankyo Company Details
11.8.2 Company Business Overview
11.8.3 Daiichi Sankyo Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Daiichi Sankyo Vitamin K Antagonists (VKA) Products Offered
11.8.5 Daiichi Sankyo Recent Development
11.9 Otsuka
11.9.1 Otsuka Company Details
11.9.2 Company Business Overview
11.9.3 Otsuka Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Otsuka Vitamin K Antagonists (VKA) Products Offered
11.9.5 Otsuka Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 Company Business Overview
11.10.3 AstraZeneca Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2014-2019)
11.10.4 AstraZeneca Vitamin K Antagonists (VKA) Products Offered
11.10.5 AstraZeneca Recent Development
11.11 Pfizer
11.12 Aspen
11.13 The Medicines Company
12 Future Forecast
12.1 Vitamin K Antagonists (VKA) Market Forecast by Regions
12.1.1 Global Vitamin K Antagonists (VKA) Sales Forecast by Regions 2019-2025
12.1.2 Global Vitamin K Antagonists (VKA) Revenue Forecast by Regions 2019-2025
12.2 Vitamin K Antagonists (VKA) Market Forecast by Product
12.2.1 Global Vitamin K Antagonists (VKA) Sales Forecast by Product 2019-2025
12.2.2 Global Vitamin K Antagonists (VKA) Revenue Forecast by Product 2019-2025
12.3 Vitamin K Antagonists (VKA) Market Forecast by End User
12.4 North America Vitamin K Antagonists (VKA) Forecast
12.5 Europe Vitamin K Antagonists (VKA) Forecast
12.6 Asia Pacific Vitamin K Antagonists (VKA) Forecast
12.7 Central & South America Vitamin K Antagonists (VKA) Forecast
12.8 Middle East and Africa Vitamin K Antagonists (VKA) Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Vitamin K Antagonists (VKA) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Vitamin K Antagonists (VKA) Product Picture
Table Vitamin K Antagonists (VKA) Market Segments
Table Key Manufacturers Vitamin K Antagonists (VKA) Covered
Table Global Vitamin K Antagonists (VKA) Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Vitamin K Antagonists (VKA) Sales Market Share by Product 2014-2025
Figure Oral Vitamin K Antagonists Product Picture
Table Major Manufacturers of Oral Vitamin K Antagonists
Figure Injection Vitamin K Antagonists Product Picture
Table Major Manufacturers of Injection Vitamin K Antagonists
Table Global Vitamin K Antagonists (VKA) Market Size Growth Rate by End User 2019-2025 (K Units)
Figure VTE
Figure ACS/MI
Figure AF
Figure Others
Figure Vitamin K Antagonists (VKA) Report Years Considered
Figure Global Vitamin K Antagonists (VKA) Market Size 2014-2025 (Million US$)
Figure Global Vitamin K Antagonists (VKA) Sales 2014-2025 (K Units)
Table Global Vitamin K Antagonists (VKA) Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Vitamin K Antagonists (VKA) Sales by Regions 2014-2019 (K Units)
Table Global Vitamin K Antagonists (VKA) Sales Market Share by Regions 2014-2019
Figure Global Vitamin K Antagonists (VKA) Sales Market Share by Regions 2014-2019
Figure 2018 Global Vitamin K Antagonists (VKA) Sales Market Share by Regions
Table Global Vitamin K Antagonists (VKA) Revenue by Regions 2014-2019 (Million US$)
Table Global Vitamin K Antagonists (VKA) Revenue Market Share by Regions 2014-2019
Figure Global Vitamin K Antagonists (VKA) Revenue Market Share by Regions 2014-2019
Figure 2018 Global Vitamin K Antagonists (VKA) Revenue Market Share by Regions
Table Global Vitamin K Antagonists (VKA) Sales by Manufacturers (2014-2019) (K Units)
Table Global Vitamin K Antagonists (VKA) Sales Share by Manufacturers (2014-2019)
Figure Global Vitamin K Antagonists (VKA) Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Vitamin K Antagonists (VKA) Revenue by Manufacturers (2014-2019) (Million USD)
Table Vitamin K Antagonists (VKA) Revenue Share by Manufacturers (2014-2019)
Figure Vitamin K Antagonists (VKA) Value Share by Manufacturers in 2018
Table Key Manufacturers Vitamin K Antagonists (VKA) Price (2014-2019) (USD/Unit)
Table Vitamin K Antagonists (VKA) Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Vitamin K Antagonists (VKA) Product Type
Table Date of International Manufacturers Enter into Vitamin K Antagonists (VKA) Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Vitamin K Antagonists (VKA) Sales by Product (2014-2019) (K Units)
Table Global Vitamin K Antagonists (VKA) Sales Share by Product (2014-2019)
Figure Global Vitamin K Antagonists (VKA) Sales Market Share by Product (2014-2019)
Figure Global Vitamin K Antagonists (VKA) Sales Market Share by Product in 2018
Table Global Vitamin K Antagonists (VKA) Revenue by Product (2014-2019) (Million US$)
Table Global Vitamin K Antagonists (VKA) Revenue Share by Product (2014-2019)
Figure Global Vitamin K Antagonists (VKA) Revenue Market Share by Product (2014-2019)
Figure Global Vitamin K Antagonists (VKA) Revenue Market Share by Product in 2018
Table Vitamin K Antagonists (VKA) Price by Product 2014-2019 (USD/Unit)
Table Global Vitamin K Antagonists (VKA) Sales by End User (2014-2019) (K Units)
Table Global Vitamin K Antagonists (VKA) Sales Share by End User (2014-2019)
Figure Global Sales Vitamin K Antagonists (VKA) Market Share by End User (2014-2019)
Figure Global Sales Vitamin K Antagonists (VKA) Market Share by End User in 2018
Figure North America Vitamin K Antagonists (VKA) Sales Growth Rate 2014-2019 (K Units)
Figure North America Vitamin K Antagonists (VKA) Revenue Growth Rate 2014-2019 (Million US$)
Table North America Vitamin K Antagonists (VKA) Sales by Countries (2014-2019) (K Units)
Table North America Vitamin K Antagonists (VKA) Sales Market Share by Countries (2014-2019)
Figure 2018 North America Vitamin K Antagonists (VKA) Sales Market Share by Countries
Table North America Vitamin K Antagonists (VKA) Revenue by Countries (2014-2019) (Million US$)
Table North America Vitamin K Antagonists (VKA) Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Vitamin K Antagonists (VKA) Revenue Market Share by Countries
Figure United States Vitamin K Antagonists (VKA) Sales Growth Rate (2014-2019) (K Units)
Figure United States Vitamin K Antagonists (VKA) Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Vitamin K Antagonists (VKA) Sales Growth Rate (2014-2019) (K Units)
Figure Canada Vitamin K Antagonists (VKA) Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Vitamin K Antagonists (VKA) Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Vitamin K Antagonists (VKA) Revenue Growth Rate (2014-2019) (Million US$)
Table North America Vitamin K Antagonists (VKA) Sales by Product (2014-2019) (K Units)
Table North America Vitamin K Antagonists (VKA) Sales Market Share by Product (2014-2019)
Figure 2018 North America Vitamin K Antagonists (VKA) Market Share by Product
Table North America Vitamin K Antagonists (VKA) Sales by End User (2014-2019) (K Units)
Table North America Vitamin K Antagonists (VKA) Sales Market Share by End User (2014-2019)
Figure 2018 North America Vitamin K Antagonists (VKA) Market Share by End User
Figure Europe Vitamin K Antagonists (VKA) Sales Growth Rate 2014-2019 (K Units)
Figure Europe Vitamin K Antagonists (VKA) Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Vitamin K Antagonists (VKA) Sales by Countries (2014-2019) (K Units)
Table Europe Vitamin K Antagonists (VKA) Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Vitamin K Antagonists (VKA) Sales Market Share by Countries
Table Europe Vitamin K Antagonists (VKA) Revenue by Countries (2014-2019) (Million US$)
Table Europe Vitamin K Antagonists (VKA) Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Vitamin K Antagonists (VKA) Revenue Market Share by Countries
Figure Germany Vitamin K Antagonists (VKA) Sales Growth Rate (2014-2019) (K Units)
Figure Germany Vitamin K Antagonists (VKA) Revenue Growth Rate (2014-2019) (Million US$)
Figure France Vitamin K Antagonists (VKA) Sales Growth Rate (2014-2019) (K Units)
Figure France Vitamin K Antagonists (VKA) Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Vitamin K Antagonists (VKA) Sales Growth Rate (2014-2019) (K Units)
Figure UK Vitamin K Antagonists (VKA) Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Vitamin K Antagonists (VKA) Sales Growth Rate (2014-2019) (K Units)
Figure Italy Vitamin K Antagonists (VKA) Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Vitamin K Antagonists (VKA) Sales Growth Rate (2014-2019) (K Units)
Figure Russia Vitamin K Antagonists (VKA) Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Vitamin K Antagonists (VKA) Sales by Product (2014-2019) (K Units)
Table Europe Vitamin K Antagonists (VKA) Sales Market Share by Product (2014-2019)
Figure 2018 Europe Vitamin K Antagonists (VKA) Market Share by Product
Table Europe Vitamin K Antagonists (VKA) Sales by End User (2014-2019) (K Units)
Table Europe Vitamin K Antagonists (VKA) Sales Market Share by End User (2014-2019)
Figure 2018 Europe Vitamin K Antagonists (VKA) Market Share by End User
Figure Asia Pacific Vitamin K Antagonists (VKA) Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Vitamin K Antagonists (VKA) Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Vitamin K Antagonists (VKA) Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Vitamin K Antagonists (VKA) Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Vitamin K Antagonists (VKA) Sales Market Share by Countries
Table Asia Pacific Vitamin K Antagonists (VKA) Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Vitamin K Antagonists (VKA) Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Vitamin K Antagonists (VKA) Revenue Market Share by Countries
Figure China Vitamin K Antagonists (VKA) Sales Growth Rate (2014-2019) (K Units)
Figure China Vitamin K Antagonists (VKA) Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Vitamin K Antagonists (VKA) Sales Growth Rate (2014-2019) (K Units)
Figure Japan Vitamin K Antagonists (VKA) Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Vitamin K Antagonists (VKA) Sales Growth Rate (2014-2019) (K Units)
Figure Korea Vitamin K Antagonists (VKA) Revenue Growth Rate (2014-2019) (Million US$)
Figure India Vitamin K Antagonists (VKA) Sales Growth Rate (2014-2019) (K Units)
Figure India Vitamin K Antagonists (VKA) Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Vitamin K Antagonists (VKA) Sales Growth Rate (2014-2019) (K Units)
Figure Australia Vitamin K Antagonists (VKA) Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Vitamin K Antagonists (VKA) Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Vitamin K Antagonists (VKA) Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Vitamin K Antagonists (VKA) Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Vitamin K Antagonists (VKA) Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Vitamin K Antagonists (VKA) Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Vitamin K Antagonists (VKA) Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Vitamin K Antagonists (VKA) Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Vitamin K Antagonists (VKA) Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Vitamin K Antagonists (VKA) Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Vitamin K Antagonists (VKA) Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Vitamin K Antagonists (VKA) Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Vitamin K Antagonists (VKA) Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Vitamin K Antagonists (VKA) Sales by Product (2014-2019) (K Units)
Table Asia Pacific Vitamin K Antagonists (VKA) Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Vitamin K Antagonists (VKA) Market Share by Product
Table Asia Pacific Vitamin K Antagonists (VKA) Sales by End User (2014-2019) (K Units)
Table Asia Pacific Vitamin K Antagonists (VKA) Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Vitamin K Antagonists (VKA) Market Share by End User
Figure Central & South America Vitamin K Antagonists (VKA) Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Vitamin K Antagonists (VKA) Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Vitamin K Antagonists (VKA) Sales by Countries (2014-2019) (K Units)
Table Central & South America Vitamin K Antagonists (VKA) Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Vitamin K Antagonists (VKA) Sales Market Share by Countries
Table Central & South America Vitamin K Antagonists (VKA) Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Vitamin K Antagonists (VKA) Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Vitamin K Antagonists (VKA) Revenue Market Share by Countries
Figure Brazil Vitamin K Antagonists (VKA) Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Vitamin K Antagonists (VKA) Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Vitamin K Antagonists (VKA) Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Vitamin K Antagonists (VKA) Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Vitamin K Antagonists (VKA) Sales by Product (2014-2019) (K Units)
Table Central & South America Vitamin K Antagonists (VKA) Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Vitamin K Antagonists (VKA) Market Share by Product
Table Central & South America Vitamin K Antagonists (VKA) Sales by End User (2014-2019) (K Units)
Table Central & South America Vitamin K Antagonists (VKA) Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Vitamin K Antagonists (VKA) Market Share by End User
Figure Middle East and Africa Vitamin K Antagonists (VKA) Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Vitamin K Antagonists (VKA) Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Vitamin K Antagonists (VKA) Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Vitamin K Antagonists (VKA) Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Vitamin K Antagonists (VKA) Sales Market Share by Countries
Table Middle East and Africa Vitamin K Antagonists (VKA) Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Vitamin K Antagonists (VKA) Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Vitamin K Antagonists (VKA) Revenue Market Share by Countries
Figure GCC Countries Vitamin K Antagonists (VKA) Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Vitamin K Antagonists (VKA) Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Vitamin K Antagonists (VKA) Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Vitamin K Antagonists (VKA) Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Vitamin K Antagonists (VKA) Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Vitamin K Antagonists (VKA) Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Vitamin K Antagonists (VKA) Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Vitamin K Antagonists (VKA) Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Vitamin K Antagonists (VKA) Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Vitamin K Antagonists (VKA) Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Vitamin K Antagonists (VKA) Market Share by Product
Table Middle East and Africa Vitamin K Antagonists (VKA) Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Vitamin K Antagonists (VKA) Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Vitamin K Antagonists (VKA) Market Share by End User
Table Sanofi Company Details
Table Sanofi Vitamin K Antagonists (VKA) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Bayer Company Details
Table Bayer Vitamin K Antagonists (VKA) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Vitamin K Antagonists (VKA) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Recent Development
Table Genentech (Roche) Company Details
Table Genentech (Roche) Vitamin K Antagonists (VKA) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Genentech (Roche) Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Lilly Company Details
Table Lilly Vitamin K Antagonists (VKA) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Lilly Recent Development
Table Daiichi Sankyo Company Details
Table Daiichi Sankyo Vitamin K Antagonists (VKA) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Daiichi Sankyo Recent Development
Table Otsuka Company Details
Table Otsuka Vitamin K Antagonists (VKA) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Otsuka Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Vitamin K Antagonists (VKA) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development
Table Pfizer Company Details
Table Aspen Company Details
Table The Medicines Company Company Details
Table Global Vitamin K Antagonists (VKA) Sales Forecast by Regions 2019-2025 (K Units)
Table Global Vitamin K Antagonists (VKA) Sales Market Share Forecast by Regions 2019-2025
Table Global Vitamin K Antagonists (VKA) Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Vitamin K Antagonists (VKA) Revenue Market Share Forecast by Regions 2019-2025
Table Global Vitamin K Antagonists (VKA) Sales Forecast by Product 2019-2025 (K Units)
Table Global Vitamin K Antagonists (VKA) Sales Market Share Forecast by Product 2019-2025
Table Global Vitamin K Antagonists (VKA) Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Vitamin K Antagonists (VKA) Revenue Market Share Forecast by Product 2019-2025
Table Global Vitamin K Antagonists (VKA) Sales Forecast by End User 2019-2025 (K Units)
Table Global Vitamin K Antagonists (VKA) Sales Market Share Forecast by End User 2019-2025
Figure North America Vitamin K Antagonists (VKA) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Vitamin K Antagonists (VKA) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Vitamin K Antagonists (VKA) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Vitamin K Antagonists (VKA) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Vitamin K Antagonists (VKA) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Vitamin K Antagonists (VKA) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Vitamin K Antagonists (VKA) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Vitamin K Antagonists (VKA) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Vitamin K Antagonists (VKA) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Vitamin K Antagonists (VKA) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Vitamin K Antagonists (VKA) Value Chain
Table Vitamin K Antagonists (VKA) Customers List
Table Vitamin K Antagonists (VKA) Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs